Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2023 $ (6,403) $ 135 $ 454,759 $ (461,298) $ 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Issuance of ordinary shares, net 10,066 $ 92 9,974    
Issuance of ordinary shares, net (in shares)   9,177,847      
Issue of warrants for ordinary shares, net 2,718   2,718    
Exercise of share options 29   29    
Exercise of share options, (in shares)   29,144      
Share-based compensation expense 274   274    
Net loss (18,192)     (18,192)  
Unrealized gain on available-for-sale securities 1       1
Ending balance at Sep. 30, 2024 (11,507) $ 227 467,754 (479,490) 2
Ending balance (in shares) at Sep. 30, 2024   22,705,994      
Beginning balance at Dec. 31, 2023 (6,403) $ 135 454,759 (461,298) 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Net loss (24,774)        
Ending balance at Dec. 31, 2024 (4,081) $ 315 481,676 (486,072)  
Ending balance (in shares) at Dec. 31, 2024   31,534,233      
Beginning balance at Jun. 30, 2024 (10,913) $ 166 462,318 (473,396) (1)
Beginning balance (in shares) at Jun. 30, 2024   16,584,029      
Issuance of ordinary shares, net 2,712 $ 61 2,651    
Issuance of ordinary shares, net (in shares)   6,121,965      
Issue of warrants for ordinary shares, net 2,718   2,718    
Share-based compensation expense 67   67    
Net loss (6,094)     (6,094)  
Unrealized gain on available-for-sale securities 3       3
Ending balance at Sep. 30, 2024 (11,507) $ 227 467,754 (479,490) $ 2
Ending balance (in shares) at Sep. 30, 2024   22,705,994      
Beginning balance at Dec. 31, 2024 (4,081) $ 315 481,676 (486,072)  
Beginning balance (in shares) at Dec. 31, 2024   31,534,233      
Issuance of ordinary shares, net 16,877 $ 175 16,702    
Issuance of ordinary shares, net (in shares)   17,431,145      
Exercise of warrants for ordinary shares (in shares)   26,482      
Exercise of warrants for ordinary shares 32   32    
Share-based compensation expense 170   170    
Net loss (20,379)     (20,379)  
Ending balance at Sep. 30, 2025 (7,381) $ 490 498,580 (506,451)  
Ending balance (in shares) at Sep. 30, 2025   48,991,860      
Beginning balance at Jun. 30, 2025 (3,887) $ 421 493,164 (497,472)  
Beginning balance (in shares) at Jun. 30, 2025   42,131,328      
Issuance of ordinary shares, net 5,432 $ 69 5,363    
Issuance of ordinary shares, net (in shares)   6,860,532      
Share-based compensation expense 53   53    
Net loss (8,979)     (8,979)  
Ending balance at Sep. 30, 2025 $ (7,381) $ 490 $ 498,580 $ (506,451)  
Ending balance (in shares) at Sep. 30, 2025   48,991,860